Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Gastrointestinal syndromes preceding a diagnosis of Parkinson's disease: testing Braak's hypothesis using a nationwide database for comparison with Alzheimer's disease and cerebrovascular diseases

Konings B, Villatoro L, Van den Eynde J, Barahona G, Burns R, McKnight M, Hui K, Yenokyan G, Tack J, Pasricha PJ.

Gut. 2023 Nov;72(11):2103-2111. doi: 10.1136/gutjnl-2023-329685. Epub 2023 Aug 24.

Blood Neurofilament Light Chain in Different Types of Dementia

Gu L, Shu H, Wang Y, Wang P.

Curr Alzheimer Res. 2023;20(3):149-160. doi: 10.2174/1567205020666230601123123.

Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update

Khan SS, Khatik GL, Datusalia AK.

Curr Neuropharmacol. 2023;21(2):309-339. doi: 10.2174/1570159X20666220411083922.

Neurodegenerative disorders: From clinicopathology convergence to systems biology divergence

Fasano M, Alberio T.

Handb Clin Neurol. 2023;192:73-86. doi: 10.1016/B978-0-323-85538-9.00007-9.

Aluminium in the Human Brain: Routes of Penetration, Toxicity, and Resulting Complications

Bryliński Ł, Kostelecka K, Woliński F, Duda P, Góra J, Granat M, Flieger J, Teresiński G, Buszewicz G, Sitarz R, Baj J.

Int J Mol Sci. 2023 Apr 13;24(8):7228. doi: 10.3390/ijms24087228.

Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways

Phukan BC, Roy R, Gahatraj I, Bhattacharya P, Borah A.

Phytother Res. 2023 Dec;37(12):5657-5699. doi: 10.1002/ptr.8012. Epub 2023 Oct 12.

Common and Trace Metals in Alzheimer's and Parkinson's Diseases

Doroszkiewicz J, Farhan JA, Mroczko J, Winkel I, Perkowski M, Mroczko B.

Int J Mol Sci. 2023 Oct 29;24(21):15721. doi: 10.3390/ijms242115721.

Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier

Vargas-Rodríguez P, Cuenca-Martagón A, Castillo-González J, Serrano-Martínez I, Luque RM, Delgado M, González-Rey E.

Int J Mol Sci. 2023 Sep 14;24(18):14117. doi: 10.3390/ijms241814117.

NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders

Zilberter Y, Tabuena DR, Zilberter M.

Prog Neurobiol. 2023 Dec;231:102539. doi: 10.1016/j.pneurobio.2023.102539. Epub 2023 Oct 12.

Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview

Alshial EE, Abdulghaney MI, Wadan AS, Abdellatif MA, Ramadan NE, Suleiman AM, Waheed N, Abdellatif M, Mohammed HS.

Life Sci. 2023 Dec 1;334:122257. doi: 10.1016/j.lfs.2023.122257. Epub 2023 Nov 8.

Altered pathophysiology in common neurological conditions

Hill B, Peate I.

Br J Nurs. 2023 Nov 23;32(21):1032-1038. doi: 10.12968/bjon.2023.32.21.1032.

Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease

Nott A, Holtman IR.

Front Immunol. 2023 Jun 8;14:1168539. doi: 10.3389/fimmu.2023.1168539. eCollection 2023.

Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review

Price S, Ruppar TM.

Appl Nurs Res. 2023 Dec;74:151745. doi: 10.1016/j.apnr.2023.151745. Epub 2023 Oct 28.

Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment

Wang M, Sajobi TT, Hogan DB, Ganesh A, Seitz DP, Chekouo T, Forkert ND, Borrie MJ, Camicioli R, Hsiung GR, Masellis M, Moorhouse P, Tartaglia MC, Ismail Z, Smith EE.

Alzheimers Dement. 2023 Oct;19(10):4542-4548. doi: 10.1002/alz.12987. Epub 2023 Mar 15.

The Emerging Role of Autophagy-Associated lncRNAs in the Pathogenesis of Neurodegenerative Diseases

Jiang Y, Xu N.

Int J Mol Sci. 2023 Jun 2;24(11):9686. doi: 10.3390/ijms24119686.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias